Induction of iMATEs through CpG-injection has also been shown to improve CD8 T cell immunity against high-level expression of a transgenic model antigen (ovalbumin) in the liver25, to increase anti-viral immunity during lymphocytic choriomeningitis virus infection14 and even increase anti-tumor immunity against liver cancer26. The gene discussed is CD8A; the disease is neoplasm.